{"url":"https://lda.senate.gov/api/v1/filings/8b4d3c58-970c-4b7b-8cef-db16b936b708/","filing_uuid":"8b4d3c58-970c-4b7b-8cef-db16b936b708","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2018,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8b4d3c58-970c-4b7b-8cef-db16b936b708/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Irene Bueno","dt_posted":"2018-07-20T17:00:53.003000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1640 Rhode Island Ave. NW","registrant_address_2":"Suite 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":76833,"url":"https://lda.senate.gov/api/v1/registrants/76833/","house_registrant_id":35960,"name":"NVG, LLC","description":"Government Relations Firm","address_1":"1640 Rhode Island Ave. NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETH ANNE COLE","contact_telephone":"+1 202-540-1070","dt_updated":"2026-07-30T15:56:39.439824-04:00"},"client":{"id":169115,"url":"https://lda.senate.gov/api/v1/clients/169115/","client_id":1002816,"name":"SANOFI US","general_description":"Pharmaceutical manufacturer","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-09-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to over the counter Monograph reform, vaccines, and the Pandemic and All-Hazards Preparedness Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":20565,"prefix":null,"prefix_display":null,"first_name":"ANDREA","nickname":null,"middle_name":null,"last_name":"LARUE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64490,"prefix":null,"prefix_display":null,"first_name":"BONNIE","nickname":null,"middle_name":null,"last_name":"HOGUE DUFFY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}